Madhu Lal‐Nag - Concepedia

Author

Madhu Lal‐Nag

National Center for Advancing Translational Sciences ORCID

Also Known As

M Lal-Nag, M. Lal-Nag, Madhu A. Lal-Nag, Madhu Lal-Nag, Madhu Lal‐Nag

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

National Center for Advancing Translational Sciences National Institutes of Health Yale University Johns Hopkins University Frederick National Laboratory for Cancer Research

About

Madhu Lal‐Nag is an author at National Center for Advancing Translational Sciences specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	1.3K
2	Natural Sciences	9	9	637
3	Biochemistry	5	5	476
4	Engineering	2	2	53
5	Health Sciences	1	1	16

Madhu Lal‐Nag

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability Berkley E. Gryder, Marielle E. Yohe, Hsien-Chao Chou, Cancer Discovery	2017	317
Assay Guidance Manual [Internet] Sarine Markossian, A Grossman, Kyle R. Brimacombe, Pharmaceutical ResearchDrug TargetBiochemistryHigh Throughput ScreeningMedicine	2004	287
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance Kunihiko Hinohara, Hua‐Jun Wu, Sébastien Vigneau, Cancer Cell Histone ModificationsChromatinChromatin RemodelingTherapeutic ResistanceNatural Sciences	2018	248
Cell Viability Assays -- Assay Guidance Manual Sittampalam Gs, Ashley Grossman, Kyle R. Brimacombe, Cell CultureCell ManipulationCell Viability AssaysMedicineCell Biology	2004	170
Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity Shyh‐Ming Yang, Natalia J. Martinez, Adam Yasgar, Journal of Medicinal Chemistry Inhibitory ActivityMedicinal ChemistryAldehyde DehydrogenaseAldo-keto ReductaseBiochemistry	2018	87
High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2 Nathan P. Coussens, Stephen C. Kales, Mark J. Henderson, Journal of Biological Chemistry Histone ModificationsChromatinChromatin RemodelingNatural SciencesEpigenetic Change	2018	74
Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1) Shyh‐Ming Yang, Adam Yasgar, Bettina Miller, Journal of Medicinal Chemistry Aldo-keto ReductaseReactive AldehydesAldehyde Dehydrogenase 1A1Chemical BiologySelective Theophylline-based Inhibitor	2015	68
Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium Louise C. Laurent, Asim B. Abdel‐Mageed, P. David Adelson, Journal of Extracellular Vesicles Exrnas LiesMolecular BiologyExtracellular MicrovesiclesTranscriptomicsExosomes	2015	66
Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells Chen Peng, Linda S. Wyatt, Shira Glushakow-Smith, PLoS Pathogens Viral ReplicationSynthetic VirologyImmunologyCancer VaccinesVirus Gene	2020	46
Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline Jens M. Kelm, Madhu Lal‐Nag, G. Sitta Sittampalam, Drug Discovery Today Translational MedicineDrug RepositioningIntegrating 3DEngineeringMedicine	2018	42

Page 1